171 related articles for article (PubMed ID: 1767757)
1. Clinical evaluation of hematopoietic growth factors.
Lindemann A; Herrmann F; Mertelsmann R
Adv Exp Med Biol; 1991; 297():93-102. PubMed ID: 1767757
[No Abstract] [Full Text] [Related]
2. [Hematopoietic growth factors].
Robak T
Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic cell growth factors. What are the expectations today?].
Foussard C; Gardembas-Pain M; Ifrah N
Rev Prat; 1992 Apr; 42(8):975-8. PubMed ID: 1621058
[No Abstract] [Full Text] [Related]
4. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.
Herrmann F; Brugger W; Kanz L; Mertelsmann R
Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732
[No Abstract] [Full Text] [Related]
5. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
6. Hematopoietic growth factor therapy of myelodysplastic syndromes.
Arcenas AG; Vadhan-Raj S
Leuk Lymphoma; 1993; 11 Suppl 2():65-9. PubMed ID: 7510197
[No Abstract] [Full Text] [Related]
7. [Hematopoietic tissue growth factors: clinical factors].
Polli EE; Foa P
Ann Ital Med Int; 1991; 6(1 Pt 1):69-81. PubMed ID: 1716450
[TBL] [Abstract][Full Text] [Related]
8. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
Greenberg PL
Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
[No Abstract] [Full Text] [Related]
9. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
[No Abstract] [Full Text] [Related]
10. [Hematopoietic growth factors].
Minerva Cardioangiol; 1990; 38(7-8):363-5. PubMed ID: 2080029
[No Abstract] [Full Text] [Related]
11. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
Ganser A; Hoelzer D
Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
[TBL] [Abstract][Full Text] [Related]
12. [Clinical use of hematopoietic growth factors].
Robak T
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
[No Abstract] [Full Text] [Related]
13. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors. Biology and clinical applications.
Groopman JE; Molina JM; Scadden DT
N Engl J Med; 1989 Nov; 321(21):1449-59. PubMed ID: 2682244
[TBL] [Abstract][Full Text] [Related]
15. [Hematopoietic growth factors--clinical applications].
Olofsson T; Lundh B
Lakartidningen; 1988 Sep; 85(39):3149-52. PubMed ID: 3264598
[No Abstract] [Full Text] [Related]
16. Haematopoietic growth factors and their therapeutic use.
Wadhwa M; Thorpe R
Thromb Haemost; 2008 May; 99(5):863-73. PubMed ID: 18449415
[TBL] [Abstract][Full Text] [Related]
17. [Hemopoietic stem cells].
Miura Y
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1721-5. PubMed ID: 2625591
[No Abstract] [Full Text] [Related]
18. [Clinical use of hematopoietic growth factors (hematopoietins)].
Ribas-Mundó M; Ribas Bruguera A; Gale RP
Med Clin (Barc); 1993 May; 100(18):707-11. PubMed ID: 8492601
[No Abstract] [Full Text] [Related]
19. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
St Onge J; Jacobson RJ
Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
[No Abstract] [Full Text] [Related]
20. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
